1. European Medicines Agency. Guideline on clinical investigation of new medicinal products for the treatment of acute coronary syndrome.https://www.ema.europa.eu/documents/scientific-guideline/guideline-clinical-investigation-new-medicinal-products-treatment-acute-coronary-syndrome-first_en.pdf. Accessed October 11, 2023..
2. European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of chronic heart failure.https://www.ema.europa.eu/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-treatment-chronic-heart-failure-revision-2_en.pdf. Accessed October 11, 2023..
3. Clinical event adjudication in cardiovascular device trials: a Food and Drug Administration perspective;Farb;Am. Heart J.,2017
4. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium;Mehran;Circulation,2011
5. When do we need clinical endpoint adjudication in clinical trials?;Held;Ups. J. Med. Sci.,2019